http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0503009-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate | 1991-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c8a1caf87fe62e5c45bc7c70b4be35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e963b3122095ed4a7d924c7cad85ab04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27dc82eb02e6c5d8e1dc7d1a47bdc67d |
publicationDate | 1992-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0503009-A1 |
titleOfInvention | Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs |
abstract | New hydrogel formulations useful for forming adhesive reservoirs for topical or transdermal administration. These formulations comprise as polymer base a polymer or a crosslinked copolymer of 2-acrylamido-2-methylpropanesulfonic acid or a salt thereof. The gels are prepared from polymerizable compositions comprising: 20% - 50% of a monofunctional monomer component, at least 75% of said component comprising 2-acrylamido-2-methylpropane sulfonic acid or a salt thereof, the remainder being selected from the group consisting of acrylic acid, water-soluble acrylic functional monomers and vinyl pyrrolidone; 30% - 50% of a glycol selected from the group consisting of compounds of the formula: HO- (C2H4O) nH, HO- (C3H6O) mH and mixtures thereof, formula in which n is between 4 and about 16 and m is 1-4; between about 0.02% and about 0.20% of a crosslinking monomer; an amount of a free radical polymerization initiator for initiating polymerization of said monofunctional monomers and said crosslinking monomer; and a therapeutically effective amount of a drug which can be administered locally or transdermally, at least about 60% of said drug being dissolved in the composition. |
priorityDate | 1990-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.